Inflammatory mediators in chronic obstructive pulmonary disease: Review of related pathogenic mechanisms and efficacy of novel targeted therapies
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2015, Vol 32, Issue 6
Abstract
Chronic obstructive pulmonary disease (COPD) is a major global health problem which is increasing in prevalence and is now the fourth leading cause of death in the US. The pathophysiological mechanisms that control the development and progression of this disease are complex, but accumulating evidence indicates that chronic inflammation and innate and adaptive immune responses play key roles. Suppression of the inflammatory response is therefore a logical approach to the treatment of COPD. This is a review of the current literature on selected lymphocyte-associated mediators and pro-inflammatory cytokines that have been particularly implicated in the pathogenesis of the disease, with a discussion of the potential role of novel targeted therapies.
Authors and Affiliations
I. PANTAZOPOULOS, C. KAMPOLIS, K. AXIOTOU, A. LOUKERI, G. TSOUKALAS
Screening for cystic fibrosis mutations:<br /> Methods for molecular diagnosis, prenatal diagnosis and carrier identification<br /> amongst high-risk individuals - the Greek experience
OBJECTIVE Cystic fibrosis (CF) is a severe autosomal recessive genetic disease, affecting 1 in 2,500 Caucasians, with 4% being asymptomatic carriers. The aim of this study was to characterize the spectrum of CF mutations...
Vaccines in sickle cell disease
Patients suffering from sickle cell disease are prone to bacterial infections, due to anatomic or functional asplenia. Active immunization against several pathogens is essential in the management of such patients. Child...
Αντισυλληπτικά και καρκίνος του μαστού
The attitudes of parents to the vaccination of children. A study in kindergartens in Athens
OBJECTIVE The Greek National Immunization Program (NIP) is the most effective public health intervention and its purpose is to eliminate mortality from the diseases for which vaccines are available. The success of the pr...
Bovine spongiform encephalopathy and Creutzfeldt-Jacob's disease 15 years later,<br /> where do we stand?<br />
No abstract available